Transcatheter mitral and tricuspid therapies
Highlighted products for this procedure
Azurion 7 C20 with FlexArm image-guided therapy system
The revolutionary Azurion with FlexArm gives you the freedom to improve and grow your minimally invasive care.
EPIQ CVxi interventional ultrasound system
90% of clinicians who saw the new EPIQ CVx felt the new TrueVue 3D photorealistic rendering improved viewing of anatomical structures, thus increasing clinical confidence.1
Better appreciate structural heart abnormalities and impacted blood flows to perform the correct procedure with confidence with Cardiac TrueVue Color and Glass. Confidently assess the mitral valve with advanced automation that can deliver the multiple measurements and functional data required for robust echo information.
EchoNavigator
In mitral valve repair EchoNavigator enables the following to elevate confidence and boost efficiency:
EchoNavigator reorients and combines ultrasound and X-ray information into a single augmented visualization for guidance and device-tissue relationship assessment.
HeartNavigator
During mitral intervention planning for annuloplasty, repair, valve replacement, paravalvular leak closure and others, HeartNavigator enables:
The HeartNavigator is a CT planning and live overlay guidance solution using automatic heart model segmentation of anatomy to improve ease of use, speed and reproducibility.
We've seen marked benefits already with Azurion: comfortable working, high resolution images and radiation doses that are 75% lower than with previous detectors. This provides "
Alan Atkinson
Principal Interventional Radiographer, Betsi Caldwaladr University Health Board
We wouldn’t have been able to develop some of these procedures unless we knew that we had cutting-edge imaging capabilities."
Dr. Adam Greenbaum
MD, FACC, FSCAI Co-Director of the Center for Structural Heart Disease, Henry Ford Hospital, Detroit, Michigan, USA
The system moves around us, instead of us having to move around the system."
Dr. Carlos E. Ruiz
M.D., Ph.D., FACC, FESC, MSCAI Director, Structural and Congenital Heart Center, Hackensack University Medical Center and The Joseph M. Sanzari Children’s Hospital, Professor of Cardiology in Pediatrics and Medicine
Customer experiences with Philips Azurion
The ability to treat one more patient per day, or in the future
This is just one of the many improvements in lab performance achieved by the Interventional Vascular Department at St. Antonius Hospital after installing the Azurion system. The first Azurion lab performance study achieved impressive results2 which have been verified by an independent third party.*
17%
44%
12%
25%
28%
100%
17%
44%
12%
25%
28%
100%
Clinical solutions for treating structural heart diseases
Azurion workflow solutions
The Azurion has been specifically designed to integrate information from multiple sources and to save procedure time through flexible and user-centric display and control options. For example:
Explore various image-guided therapy procedures for structural heart disease
-
![TAVR / TAVI procedures]()
TAVR / TAVI procedures
Solutions for TAVR and TAVI procedures offered by Philips image-guided therapy.
Lisätietoja -
![Left atrial appendage occlusion (LAAO)]()
Left atrial appendage occlusion (LAAO)
Solutions for Left Atrial Appendage Occlusion (LAAO) procedures offered by Philips image-guided therapy.
Lisätietoja
Disclaimer Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country. References 1 Results obtained during user demonstrations performed in December 2017 with the EPIQ CVx and the iE33 systems. The research was designed and supervised by Use-Lab GmbH, an independent and objective engineering consultancy and user interface design company. The tests involved 42 clinicians from 17 countries. The various types of cardiac customer segments represented were adult diagnostics and interventional, adult diagnostics, and pediatric diagnostics and interventional. (Based on responses from 42 respondents.) Using the 3D Auto MV feature can reduce the time to analyze the mitral valve by 43% on average compared with MVN. (Results based on internal comparison between 3D Auto MV and MVN on a set of 15 3D MV datasets including both normal subjects and patients affected by mitral valve disease.) 2 100%: Compared to the suites with Azurion 7 C20. Evaluated with clinical users in a simulated lab environment after approximately 20 minutes of practicing C-arm and table positioning. * Results are specific to the institution, where they were obtained. Results in other institutions may vary.
